Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 64.58% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 21.31% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -15.03% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -7.46% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 409.20% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 30.94% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -22.30% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -150.40% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -17.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.25% |
| Mar 31, 2026 | 37.78% |
| Dec 31, 2025 | 18.10% |
| Sep 30, 2025 | -50.91% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 26.66% |
| Dec 31, 2024 | -34.92% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -51.77% |
| Mar 31, 2024 | -93.18% |
| Dec 31, 2023 | 4.03% |
| Sep 30, 2023 | 30.50% |
| Jun 30, 2023 | 74.31% |
| Mar 31, 2023 | 78.43% |
| Sep 30, 2022 | 43.58% |
| Jun 30, 2022 | -70.77% |
| Mar 31, 2022 | -275.08% |
| Sep 30, 2021 | -755.77% |
| Jun 30, 2021 | -169.44% |
| Mar 31, 2021 | -23.00% |